Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 3/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | KDM5A | P29375 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31705606 | 0.90 | L3MBTL1 (0.56) | L3MBTL1TDP1AHRJAK2ZAP70 | |
| SCHEMBL15945902 | 0.90 | L3MBTL1 (0.56) | L3MBTL1TDP1AHRJAK2ZAP70 | |
| SCHEMBL19108516 | 0.88 | L3MBTL1 (0.46) | L3MBTL1TDP1AHRJAK2ZAP70 | |
| SCHEMBL23242811 | 0.84 | MAPT (0.50) | L3MBTL1AHRKDM4EHPGDALDH1A1 | |
| SCHEMBL31668235 | 0.84 | AHR (0.46) | L3MBTL1AHRJAK2ZAP70SYK | |
| SCHEMBL24039790 | 0.84 | AHR (0.46) | L3MBTL1AHRJAK2ZAP70SYK | |
| SCHEMBL14476381 | 0.84 | AHR (0.46) | L3MBTL1AHRJAK2ZAP70SYK | |
| SCHEMBL23987596 | 0.84 | L3MBTL1 (0.42) | L3MBTL1TDP1AHRJAK2ZAP70 | |
| SCHEMBL22071327 | 0.84 | AHR (0.47) | L3MBTL1TDP1AHRJAK2ZAP70 | |
| SCHEMBL22155842 | 0.84 | L3MBTL1 (0.42) | L3MBTL1TDP1AHRJAK2ZAP70 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-06-19 | — | — | US | disclosed |
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2018-06-19 | — | — | US | disclosed |
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349276-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | ORAI2, ESR1, OR10J3 | L3MBTL1 569/4885TDP1 2054/4885AHR 1479/4885 |
| US-10003031-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | ORAI2, ESR1, OR10J3 | L3MBTL1 569/4885TDP1 2054/4885AHR 1479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.